hsa_circ_0002872 functions in lung cancer prognostic and tumorigenesis through regulating ZBTB46 via sponging hsa-miR-29b-1-5p
Clinics · 2025
DOI: 10.1016/j.clinsp.2025.100733 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinics, 2025. Verfasst von Xifan Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, The Second Hospital of Nanjing, Affiliated to Nanjing University of Chinese Medicine, Nanjing 210003, Jiangsu, China. Hauptthemen laut MEDLINE: Lung Neoplasms, RNA, Circular, MicroRNAs, Transcription Factors. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Health Commission of the People's Republic of China, Nanjing Jinling Hospital.
Abstract (Originalsprache)
Background
Lung cancer is a leading cause of cancer deaths worldwide, underscoring the need for new biomarkers. Circular RNAs (circRNAs) exhibit potential as biomarkers for lung cancer. ZBTB46 is linked to lung cancer prognosis. This study intends to investigate circRNA expression and the role of ZBTB46 in predicting and treating lung cancer.
Methods
CircRNAs demonstrate differential expression in lung cancer and paracarcinoma tissues, as identified by high-throughput sequencing (RNA-seq). DEcircRNAs were analyzed through GO and KEGG analyses. A potential circRNA-miRNA-mRNA axis was predicted based on ceRNA theory. ZBTB46 expression in lung cancer tissue was compared to normal tissue. Using the TCGA database, protein expression was compared through the CPTAC and HPA databases.
Results
We identified 411 differentially expressed circRNAs, of which 365 were down-regulated and 46 were up-regulated. By combining qRT-PCR validation results, ceRNA theory, and intersecting data from several databases, hsa_circ_0002872/hsa-miR-29b-1-5p/ZBTB46 was predicted as the most promising downstream regulatory axis. ZBTB46 mRNA and protein expression were reduced in human lung cancer tissue compared to normal tissue. Conclusions hsa_circ_0002872/hsa-miR-29b-1-5p/ZBTB46 represents an axis that may influence lung cancer progression, with the molecule ZBTB46 potentially inhibiting lung cancer progression and serving as a useful prognostic indicator.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, The Second Hospital of Nanjing, Affiliated to Nanjing University of Chinese Medicine, Nanjing 210003, Jiangsu, China.
- Institute of Laboratory Medicine, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing 210002, Jiangsu, China.
- Department of Oncology, The Second Hospital of Nanjing, Affiliated to Nanjing University of Chinese Medicine, Nanjing 210003, Jiangsu, China. Electronic address: zhucd@njucm.edu.cn.
- Institute of Laboratory Medicine, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing 210002, Jiangsu, China; The First School of Clinical Medicine, Southern Medical University, Guangzho…
Förderung
- National Natural Science Foundation of China
- National Health Commission of the People's Republic of China
- Nanjing Jinling Hospital
Zitieren
APA
Wang, X., Song, X., Wei, H., Li, X., Li, H., Zhu, Y., Zhu, C., & Chen, F. (2025). hsa_circ_0002872 functions in lung cancer prognostic and tumorigenesis through regulating ZBTB46 via sponging hsa-miR-29b-1-5p. Clinics. https://doi.org/10.1016/j.clinsp.2025.100733
Vancouver
Wang X, Song X, Wei H, Li X, Li H, Zhu Y, et al. hsa_circ_0002872 functions in lung cancer prognostic and tumorigenesis through regulating ZBTB46 via sponging hsa-miR-29b-1-5p. Clinics. 2025. doi:10.1016/j.clinsp.2025.100733
BibTeX
@article{Wang2025,
author = {Wang, Xifan and Song, Xiaoyan and Wei, Hongxuan and Li, Xiaoqing and Li, Huihui and Zhu, Yan and Zhu, Chuandong and Chen, Fangfang},
title = {hsa_circ_0002872 functions in lung cancer prognostic and tumorigenesis through regulating ZBTB46 via sponging hsa-miR-29b-1-5p},
journal = {Clinics},
year = {2025},
doi = {10.1016/j.clinsp.2025.100733}
}
EUVIMED